DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 117 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $20,000 | +150.0% | 2,201 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -33.3% | 2,201 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | +50.0% | 2,201 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | -11.1% | 2,201 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -43.8% | 2,201 | 0.0% | 0.00% | – |
| Q1 2019 | $16,000 | -20.0% | 2,201 | 0.0% | 0.00% | – |
| Q4 2018 | $20,000 | -25.9% | 2,201 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -12.9% | 2,201 | +10.0% | 0.00% | -100.0% |
| Q2 2018 | $31,000 | -22.5% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $40,000 | +233.3% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $12,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |